Focal photocoagulation less invasive for microaneurysms

Article

Focal photocoagulation may be a less invasive method for the treatment of microaneurysms, according to a paper published in the journal Retina.

Focal photocoagulation may be a less invasive method for the treatment of microaneurysms, according to a paper published in the journal Retina.

A team led by Dr Y. Yamada, Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan, analysed 13 eyes of diabetic patients who underwent focal photocoagulation for clinically significant macula oedema.

The microaneurysms were evaluated preoperatively, immediately postoperatively and one and two months after photocoagulation with SD-OCT. Fluorescein angiography and colour fundus photography were also used to evaluate the microaneurysms.

Preoperatively, the microaneurysms were circular or elliptical in structure with hyperreflective foci within vessel walls. Immediately after the procedure there were indistinct lesions with hyperreflectivity around the microaneurysms.

Efficient photocoagulations procedures resulted in retinal changes limited to within the inner retina around the microaneurysms and there were no changes in the retinal pigment epithelium. Within two postoperative months the microaneurysms transformed into fine scars and the retinal structure was normalized.

The average retinal foveal thickness increased from 432 ± 70 μm preoperatively to 373 ± 84 μm at the two-month follow-up. SD-OCT is useful for assessing the efficacy of photocoagulations procedures.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.